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The endovascular treatment of a renal
arteriovenous fistula: Placement of a covered stent
L. Richard Sprouse II, MD, and Ian N. Hamilton, Jr, MD, FACS, Chattanooga, Tenn
We describe the case of a 40-year-old man with an acquired renal arteriovenous fistula (AVF) treated with endovascular
placement of a homemade polytetrafluoroethylene covered Palmaz stent (Johnson & Johnson, Warren, NJ). The patient
was seen with a abdominal bruit 5 years after exploratory laparotomy for multiple knife stab wounds. An abdominal
computed tomographic scan showed an atrophic right kidney and enlarged right renal vein and inferior vena cava.
Arteriography confirmed a 5-mm to 7-mm AVF between the right renal artery and vein. In November 1999, the patient
was taken to the operating room where a Palmaz 308 polytetrafluoroethylene covered stent was placed within the renal
artery at the site of the fistula. Exclusion of the fistula was confirmed with arteriogram. To our knowledge, this is one of
the earliest reports and the longest follow-up of the endovascular placement of a covered stent for treatment of an
acquired renal AVF. Continued application of covered stent treatment for renal AVFs should prove less expensive with
improved renal preservation and, with prefabricated stent grafts, prove less cumbersome and time consuming than coil
embolization. (J Vasc Surg 2002;36:1066-8.)
Transcatheter embolization is the preferred treatment
for most congenital and acquired renal arteriovenous fistu-
lae (AVFs). A variety of materials has been used for embo-
lization, and this technique is especially effective for intra-
renal AVFs that commonly occur after percutaneous
biopsy.1-4 However, transcatheter embolization has been
less successful, and often dangerous, for treatment of AVFs
of the main renal artery and vein. The risk of systemic
embolization, among other complications, remains a con-
cern with large AVFs, and most authors recommend direct
surgical repair in this setting.1,5,6 We report on the treat-
ment of a large renal AVF with endovascular placement of a
homemade polytetrafluoroethylene covered stent.
CASE REPORT
A 40-year-old man was seen by his primary care physician with
intermittent right flank and postprandial abdominal pain. Previ-
ously, the patient had sustained multiple abdominal knife stab
wounds and had undergone exploratory laparotomy with repair of
both small and large bowel enterotomies along with a splenec-
tomy, hepatorrhaphy, and exploration of the right retroperito-
neum and kidney. The patient subsequently needed two reexplora-
tions for a right upper quadrant abscess. After this, a colocutaneous
fistula developed involving the hepatic flexure, and at a final
reexploration, the abdomen was left open. The patient later under-
went split-thickness skin grafting to the abdominal wall.
Five years later, the patient was seen with the previously
mentioned symptom of abdominal pain. His blood pressure was
142/84 mm Hg. Auscultation of the abdomen detected a loud
right upper quadrant abdominal bruit. An abdominal computed
tomographic (CT) scan showed an atrophic right kidney (7.0 cm in
length) and an enlarged right renal vein and inferior vena cava (Fig
1). Arteriography confirmed a 5-mm to 7-mm AVF between the
main right renal artery and vein.
The patient was taken to the operating room for placement of
an intraarterial, polytetrafluoroethylene (Impra, Tempe, Ariz) cov-
ered stent across the fistula. The right common femoral artery was
exposed, and with fluoroscopic guidance, a 6F sheath dilator was
inserted in a retrograde fashion over a floppy tip guidewire (0.035
in, 180 cm) into the pararenal aorta. Heparin (5000 units) was
given intravenously. With a 5F, C-2 guiding catheter (Johnson &
Johnson, Warren, NJ), the right renal artery was selectively cathe-
terized. Renal arteriography again showed a main right renal artery
to vein fistula. Intravascular ultrasound scan (IVUS) identified a
5-mm segment of normal renal artery proximal to the fistula and a
20-mm segment of normal renal artery distal and specifically
localized the fistula (6.2 mm  15.0 mm) to the posterior wall of
the artery.
A homemade polytetrafluoroethylene covered Palmaz 308
stent (Johnson & Johnson) was manufactured with a 6 mm 4 cm
Marshall angioplasty balloon catheter (Boston Scientific, Boston,
Mass) to overinflate a 3 mm–diameter polytetrafluoroethylene
graft. A 2.5-cm segment of the dilated polytetrafluoroethylene was
sutured to the stent at each end with interrupted 6-0 monofilament
suture. The covered stent then was loaded onto a 7 mm  3 cm
Marshall angioplasty balloon catheter.
The 6F sheath dilator was exchanged for a 16F sheath dilator
(Cook, Bloomington, Ind) that was advanced into the right renal
artery over a superstiff Amplantz wire (Boston Scientific). Next,
the dilator was removed, leaving the 16F sheath properly posi-
tioned within the renal artery across the fistula. The distal 4 cm of
a 14F sheath dilator (Cook) then was placed through the hemo-
static valve of the 16F sheath. This provided protection for the
balloon mounted covered stent, which was advanced over the
Amplantz wire into the lumen of the 16F sheath through the short
segment of 14F sheath. After the covered stent was safely beyond
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the hemostatic valve inside the 16F sheath, the 14F sheath was
backed out of the hemostatic valve.
The covered stent was advanced inside the 16F sheath and
positioned in the renal artery at the site of the fistula. The 16F
sheath then was withdrawn back into the aorta, and the covered
stent was deployed across the fistula with inflation of a 7 mm  3
cm angioplasty balloon catheter to 12 atm of pressure. Completion
angiography confirmed exclusion of the fistula and rapid filling of
the renal vasculature without dissection or extravasation of con-
trast (Fig 2). The guidewire and sheath were removed, and the
femoral artery was repaired primarily.
On postoperative day 1, the patient had no abdominal pain
and tolerated a regular diet without discomfort. No bruit could be
heard on physical examination, and the patient was discharged
with a blood pressure of 144/84 mm Hg and a serum creatinine
level of 0.8 mg/dL. At the 1-month follow-up, the patient had
gained 10 pounds, remained normotensive, and again had a nor-
mal serum creatinine level (0.9 mg/dL). The patient continued to
do well without reintervention, and at 2 years after stent place-
ment, a renal scan showed function of the right kidney (5% to 10%
of total). CT angiogram showed no further renal atrophy and
confirmed flow to the kidney.
DISCUSSION
The success of covered stents placed with endovascular
techniques for the treatment of peripheral aneurysms and
fistulas is well documented.7 Rikimaru et al8 also recently
treated a large renal artery aneurysm with a vein-covered
stent. Our report describes the placement of a homemade
polytetrafluoroethylene covered stent for the treatment of a
large renal AVF. To our knowledge, this has not been
reported previously.
Despite the success of transcatheter embolization for
the treatment of small intrarenal AVFs, the concern for
inadvertent central or pulmonary embolization has limited
the use of this technique for the treatment of large fistu-
las.1,5 In addition to being large, the fistula in our patient
involved the main renal artery and vein. In such cases,
transcatheter embolization is seen as especially hazardous
and is not recommended.3,6,9 Several other complications
of embolization therapy, including the ‘‘postembolization
syndrome,’’ have been reported. This can lead to unneces-
sary morbidity and clinical uncertainty in the immediate
postoperative period. We elected against embolization
therapy in our patient because it would have been danger-
ous and, most likely, unsuccessful in achieving closure of
the fistula.
In many cases, the safest and most effective treatment
for renal AVFs involving the main renal artery and vein is
open surgical repair with fistula ligation. A transperitoneal
approach with early vascular control at the renal pedicle is
recommended.1,2,6 However, the fistula can be hard to
identify, and in the ‘‘presence of thin-walled, dilated veins
and channels, surgery can be challenging.’’1 Occasionally,
an attempt at surgical repair leads to partial or complete
nephrectomy.1,4 Previous infection in the right upper
quadrant and retroperitoneum, a colocutaneous fistula in-
volving the hepatic flexure, and multiple explorations left
our patient with a hostile abdomen and rendered his con-
dition unattractive for any form of open surgical repair or
nephrectomy.
The risks of transcatheter embolization and the mor-
bidity of surgical repair were avoided in our case. Endovas-
cular placement of a covered stent provided our patient a
minimally invasive procedure that was both safe and effec-
tive and allowed for renal preservation. The primary goal
was to achieve closure of the fistula, and this was accom-
plished with minimal morbidity and without complica-
tions. Our patient’s symptoms resolved after surgery, and
there is no evidence of fistula recurrence at 2 years of
follow-up. In addition, placement of the covered stent
allowed for renal preservation. Nuclear scanning demon-
strated reduced function of the right kidney by showing
that it was only contributing to 5% to 10% of the total renal
Fig 1. Abdominal CT scan shows atrophic right kidney and dilated right renal vein and inferior vena cava.
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function. Despite this fact, the patient has no significant
change in preoperative and postoperative blood pressure or
serum creatinine level. More importantly, CT scan at the
2-year follow-up shows no further atrophy of the kidney.
That the covered stent improved renal blood flow and
prevented further deterioration of renal function and mass
is likely.
The choice to use a polytetrafluoroethylene covered
stent in our case was a matter of personal preference. We
have found polytetrafluoroethylene useful in similar situa-
tions; however, a variety of other coverings, including vein,
provide an acceptable alternative. Manufactured covered
stents are now commercially available. These devices allow
a covered stent to be introduced with a smaller arterial
sheath than necessary for our patient and may prove to be
technically less challenging to deploy than homemade cov-
ered stents. In our case, placement of the covered stent was
more accurate with the use of IVUS. We found IVUS to be
of value in defining the anatomic relationship between the
normal renal artery and the fistula. With IVUS, we were
able to identify a proximal segment of renal artery that was
necessary for successful stent placement. It also showed that
the fistula was considerably larger than predicted with
arteriography and, therefore, allowed for more accurate
placement of an appropriately sized covered stent.
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Fig 2. Completion angiography after covered stent deployment.
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